617 related articles for article (PubMed ID: 28408296)
1. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
3. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
4. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation is an effective treatment option for small renal masses, comparable to partial nephrectomy.
Pedraza-Sánchez JP; Chaves-Marcos R; Mazuecos-Quirós J; Bisonó-Castillo ÁL; Osmán-García I; Gutiérrez-Marín CM; Medina López RA; Juárez Soto Á
Eur Radiol; 2023 Nov; 33(11):7371-7379. PubMed ID: 37280356
[TBL] [Abstract][Full Text] [Related]
6. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
[TBL] [Abstract][Full Text] [Related]
8. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
10. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
11. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
12. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
[TBL] [Abstract][Full Text] [Related]
13. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
14. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
Xue Z; Tang S; Ou J; Fang Y; Qiu M; Hong K; Tian X; Zhang H; Liu C; Ma L; Zhang S
World J Urol; 2024 May; 42(1):364. PubMed ID: 38819448
[TBL] [Abstract][Full Text] [Related]
15. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes.
Chang X; Zhang F; Liu T; Ji C; Zhao X; Yang R; Yan X; Wang W; Guo H
J Urol; 2015 Feb; 193(2):430-5. PubMed ID: 25106899
[TBL] [Abstract][Full Text] [Related]
16. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
17. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
18. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
[TBL] [Abstract][Full Text] [Related]
20. Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinoma.
Hu X; Wang Y; Shao Y; Wu K; Tang Y; Ren S; Li X
Eur J Surg Oncol; 2023 Aug; 49(8):1519-1523. PubMed ID: 36958950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
